Cansortium Announces Opening of its 15th Fluent™ Medical Marijuana Dispensary in Florida and Plans to Have 6 Additional Open by the End of the Year
MIAMI, Sept. 9, 2019 /PRNewswire/ - Cansortium Inc. ("Cansortium" or the "Company") (CSE: TIUM), a vertically-integrated, global provider of premium-quality medical cannabis operating under the Fluent™ brand, continues to expand its Florida retail footprint with the September 9th opening of a new Fluent dispensary in a prime location in Cape Coral, FL.
Cansortium's Chief Executive Officer Jose Hidalgo noted, "As one of the first five licensed operators in Florida - the state with the fastest-growing medical marijuana patient population in the U.S. – we continue to capitalize on our first-mover position, executing our growth plan by steadily expanding our dispensary network to enhance access to our premium-quality Fluent cannabis products for medical marijuana patients across the state. We expect to open 6 more which will result in 21 Florida locations operating and generating revenue by the end of 2019. We currently have 18 locations secured for this continuing expansion.
"We recently commenced cultivation at Phase 2 of our state-of-the-art Tampa cultivation facility, which will more than triple our overall Florida production capacity when fully propagated. We expect this additional capacity to support the continued planned expansion of our Florida dispensary platform throughout the remainder of 2019 and into 2020."
The new 3,440 square-foot dispensary is the Company's 15th in Florida and is conveniently located in central Cape Coral at 103 SW 3rd Place, the new dispensary will serve the city's approximately 183,000 residents, as well as customers in the northern section of nearby Fort Myers.
The Fluent brand continually strives to set the standard for premium quality, consistently-formulated cannabis products. Each of the Company's Florida dispensaries carries a complete assortment of Fluent premium dried flower, and full spectrum concentrates and cartridges as well as creams, drops, capsules and suppositories. All Fluent products in the Company's Florida dispensaries use high-quality cannabis that is cultivated, processed and packaged in our state-of-the-art Florida facilities in strict compliance with Florida regulations. For consumers, the sleek, modern dispensaries provide a warm, welcoming, professional environment, with private consultation rooms and knowledgeable staff who carefully guide patients in selecting the right products and carefully safeguard patient privacy.
For a complete list of Fluent dispensary locations, current promotions and rewards programs and hours of operation, or to explore the entire Fluent product line and place an online order for home delivery anywhere in Florida, visit https://getfluent.com/.
ABOUT CANSORTIUM INC.
Cansortium is a global medical cannabis company operating in highly populous medical cannabis markets with a mission to deliver the highest standards of cannabis care from nursery to lab to shelf. Headquartered in Miami, FL and operating under the recently-launched Fluent™ brand (formerly Knox Medical), the Company through its subsidiaries operates cultivation, processing and dispensary facilities across Florida, Texas, Puerto Rico and a dispensary license in Pennsylvania. The Company also has licensed cultivation facilities in Colombia and Canada with licensing pending in Michigan.
Cansortium Inc.'s common shares and warrants trade on the CSE under the symbol "TIUM.U" and "TIUM.WT.U", respectively, and on the OTCQB Venture Market under the symbol (OTCQB: CNTMF). Investors can find current financial disclosure and Real-Time Level 2 quotes for the Company on www.otcmarkets.com.
Certain information in this news release, may constitute forward-looking information. In some cases, but not necessarily in all cases, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "targets", "expects" or "does not expect", "is expected", "an opportunity exists", "is positioned", "estimates", "intends", "assumes", "anticipates" or "does not anticipate" or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", "will" or "will be taken", "occur" or "be achieved". In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management's expectations, estimates and projections regarding future events.
Forward-looking information is necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by the Company as of the date of this news release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to the factors described in the public documents of the Company available at www.sedar.com. These factors are not intended to represent a complete list of the factors that could affect the Company; however, these factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. The forward-looking statements contained in this news release are made as of the date of this news release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.
For information on Cansortium Inc., please visit www.cansortium.com.
SOURCE Cansortium Inc